| 1 |
Ann E. Weber |
Merck |
5 |
| 2 |
Christopher L. Lynch |
Abbott |
4 |
| 2 |
Xin Gu |
Merck |
4 |
| 2 |
Charles G. Caldwell |
Merck |
4 |
| 2 |
Gee-Hong Kuo |
Johnson & Johnson |
4 |
| #6 |
Ruisong Xu |
Transitions Optical |
3 |
| #6 |
William Bickford |
Elc Management |
3 |
| #6 |
Allan James Bruce |
Sunlight Photonics |
3 |
| #9 |
Thomas Bara |
Merck |
2 |
| #9 |
John C. Chabala |
Merck |
2 |
| #9 |
Dmitri Pissarnitski |
Merck |
2 |
| #9 |
Steven L. Greenspan |
Ca |
2 |
| #9 |
Eric Neumann |
Display Technologies |
2 |
| #9 |
Richard W. Renfree |
Rutgers, The State University Of New Jersey |
2 |
| #9 |
Zhiqiang Zhao |
Merck |
2 |
| #9 |
Rafael Ben-Michael |
AT&T |
2 |
| #9 |
Jack D. Scott |
Merck |
2 |
| #9 |
Michael P. Dwyer |
Schering |
2 |
| #9 |
Steven A. Squashic |
Vertical Pharmaceuticals |
2 |
| #9 |
John R. Thompson |
Merck |
2 |
| #21 |
Put Cheung |
Open Invention Network Llc Nc |
1 |
| #21 |
Justin C. Lewis |
Wal-Mart Stores |
1 |
| #21 |
Eugene Louis Benfatti |
— |
1 |
| #21 |
Satish S. Tamhankar |
The Boc Group Limited |
1 |
| #21 |
David Sleat |
University Of Medicine And Dentistry Of New Jersey |
1 |
| #21 |
Katherine H. Guo |
Alcatel Lucent |
1 |
| #21 |
Anil Chaturvedi |
AT&T |
1 |
| #21 |
John S. Debenham |
Merck |
1 |
| #21 |
William J. Leighton, III |
AT&T |
1 |
| #21 |
Julius J. Matasi |
Schering |
1 |
| #21 |
Frances A. Bouffard |
Merck |
1 |
| #21 |
Eric A. Lieberman |
Ric Investments |
1 |
| #21 |
Naresh Ramnath Shanbhag |
Finisar |
1 |
| #21 |
Frank R. Besson |
— |
1 |
| #21 |
Jing Su |
Merck |
1 |
| #21 |
Michael Miller |
Merck |
1 |
| #21 |
Christina B. Madsen-Duggan |
Merck |
1 |
| #21 |
Richard N. Ingram |
Schering |
1 |
| #21 |
Darrell W. Brownawell |
ExxonMobil |
1 |
| #21 |
Kaustubb Joshi |
AT&T |
1 |
| #21 |
Jeffrey W. Warmke |
Merck |
1 |
| #21 |
Kim Ann O'Neill |
Schering |
1 |
| #21 |
Frederick W. Girshick |
Infineum International Limited |
1 |
| #21 |
Elizabeth M. Naylor |
Merck |
1 |
| #21 |
Doris F. Cully |
Merial |
1 |
| #21 |
William Kevin Kelly |
Sloan Kettering Institute For Cancer Research |
1 |
| #21 |
Nicholas J. S. Huby |
Hoffmann-La Roche |
1 |
| #21 |
Allan Wilks |
AT&T |
1 |
| #21 |
Amy R. Bittner |
Merck |
1 |
| #21 |
Michele Diegman |
Osteotech |
1 |